Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines

Area of Science:

• Oncology and Pharmacology

Background:

• Cancer remains a major global health challenge, causing significant morbidity and mortality worldwide.
• Apoptosis, or programmed cell death, is crucial for normal development and tissue balance, and is implicated in cancer survival.
• Targeting apoptosis pathways is a vital strategy in developing new anticancer drugs.

Purpose of the Study:

• To comprehensively review the role, pharmacology, and mechanisms of traditional Chinese medicines (TCMs) and their derivatives in targeting cancer cell apoptosis.
• To highlight the clinical implications of TCMs in cancer therapy through their effects on apoptotic pathways.

Main Methods:

• Literature review of studies on anticancer TCMs and their derivatives.
• Analysis of research focusing on the mechanisms by which these agents affect cellular apoptotic pathways.
• Synthesis of information on the pharmacology and biological roles of selected TCMs.

Main Results:

• Numerous TCMs and their derivatives have been identified as effective anticancer agents by modulating apoptosis.
• These agents demonstrate clinically beneficial effects in cancer therapy by targeting cancer cell death pathways.
• The review consolidates information on the diverse mechanisms through which TCMs induce apoptosis in cancer cells.

Conclusions:

• TCMs represent a promising source for novel anticancer drug discovery, primarily through their ability to target and manipulate cancer cell apoptosis.
• Understanding the specific mechanisms of action of these agents can lead to improved and more targeted cancer therapies.
• Further research into TCMs holds significant potential for advancing cancer treatment strategies.